CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Authors: Shiao-Pei Weathers, Carlos Kamiya-Matsuoka, Nazanin Majd, Alda Ashu, Chantell Thompson, Evguenia Gachimova, Ashley Aaroe, Chirag Patel, Monica Loghin, Barbara O'Brien, W K Alfred Yung, Vinay Puduvalli, John de Groot

Published: 2023-11-11

DOI: 10.1093/neuonc/noad179.0263

Source: Full article

CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Abstract